glycosidases, reaction with glycosyltransferases, acid hy-
drolysis of the former anomeric acetal, and ꢀ-elimination
from the serine.
ically the R- or ꢀ-anomeric C-linkage, 4 and 5, respectively,
from the common intermediate 6.
The known gluco-heptenitol 2 was available in one step
by addition of divinylzinc to 2,3,5-tri-O-benzyl arabinose.9
The divinylzinc addition is remarkably stereoselective, and
the crude product is used directly in the next step. The
metathesis partner, allyl glycine 3, was produced by protec-
tion of the commercially available allyl glycine. As shown
in Scheme 1, Yamaguchi or DCC-activated esterification of
Several syntheses of R-C-glycopyranosyl serines4 and ꢀ-C-
glycopyranosyl serines4a,e,5 have been reported. In most
cases, the stereochemistry of the C-linkage to the carbohy-
drate is first established with a pendant functional group,
which is utilized to elaborate the amino acid moiety. The
one exception being the exoalkylidene hydrogenation to
afford the ꢀ-C-linkage.5e,f In addition to these strategies,
cross-metathesis (CM) has been employed to join C-vinyl
glycosides with vinyl glycine surrogates to furnish glycosyl
serine mimics. In general, these have only produced low
yields of CM product.6
Scheme 1. Nonselective Esterification of Diol 2
Previously, we have reported the synthesis of R-C-glycosyl
serine 4 through an intramolecular hydroalkoxylation of the
(E)-4-decenoate 1.7 This cyclization precursor was prepared
by CM of the readily available gluco-heptenitol 2 and L-allyl
glycine 3, as illustrated in Figure 1. Unfortunately, both
the heptenitol 2 with the acid 3 yielded mixtures of products
with a slight preference for the nonallylic ester 7 over the
allylic ester 8 in a ∼3:2 ratio by mass after separation of
products. Neither Bu2SnO10 nor Ag2O,11 which are useful
for selective reaction of vicinal diols, were of any use in
(4) (a) Dondoni, A.; Marra, A.; Massi, A. J. Org. Chem. 1999, 64, 933–
944. (b) Debenham, S. D.; Debenham, J. S.; Burk, M. J.; Toone, E. J. J. Am.
Chem. Soc. 1997, 119, 9897–9898. (c) Urban, D.; Skrydstrup, T.; Beau,
J.-M. Chem. Commun. 1998, 955–956. (d) Rohrig, C. H.; Takhi, M.;
Schmidt, R. R. Synlett 2001, 1170–1172. (e) Dondoni, A.; Marra, A.; Massi,
A. Chem. Commun. 1998, 1741–1742. (f) Ben, R. N.; Orellana, A.; Arya,
P. J. Org. Chem. 1998, 63, 4817–4820. (g) Dorgan, B. J.; Jackson, R. F. W.
Synlett 1996, 859–861. (h) Dondoni, H.; Catozzi, N.; Marra, A. J. Org.
Chem. 2004, 69, 5023–5036. (i) Nolen, E. G.; Watts, M. M.; Fowler, D. J.
Org. Lett. 2002, 4, 3963–3965.
(5) (a) Bertozzi, C. R.; Hoeprich, P. D.; Bednarski, M. D. J. Org. Chem.
1992, 114, 6092–6094. (b) Dondoni, A.; Marra, A.; Massi, A. Tetrahedron
1998, 54, 2827–2832. (c) Campbell, A. D.; Paterson, D. E.; Taylor, R. J. K.;
Raynham, T. M. Chem. Commun. 1999, 1599–1600. (d) Ohnishi, Y.;
Ichikawa, Y. Bioorg. Med. Chem. Lett. 2002, 12, 997–999. (e) Modica, E.;
Compostella, F.; Colombo, D.; Franchini, L.; Cavallari, M.; Mori, L.; De
Libero, G.; Panza, L.; Ronchetti, F. Org. Lett. 2006, 3, 3255–3258. (f) Lay,
L.; Meldal, M.; Nicotra, F.; Panza, L.; Russo, G. Chem. Commun. 1997,
1469–1470. (g) Dondoni, A.; Mariotti, G.; Marra, A.; Massi, A. Synthesis
2001, 2129–2137.
Figure 1. Retrosynthetic plan and the common intermediate.
(6) (a) McGarvey, G. J.; Benedum, T. E.; Schmidtmann, F. W. Org.
Lett. 2002, 4, 3591–3594. (b) Nolen, E. G.; Kurish, A. J.; Wong, K. A.;
Orlando, M. D. Tetrahedron Lett. 2003, 44, 2449–2453. (c) Chen, G.;
Schmieg, J.; Tsuji, M.; Franck, R. W. Org. Lett. 2004, 6, 4077–4080.
(7) (a) Nolen, E. G.; Kurish, A. J.; Potter, J. M.; Donahue, L. A.;
Orlando, M. D. Org. Lett. 2005, 7, 3383–3386. Structures related to
compound 11 have been reported for the preparation of dysiherbaine and
neodysiherbaine. (b) Sakai, R.; Kamiya, H.; Murata, M.; Shimamoto, K.
J. Am. Chem. Soc. 1997, 119, 4112–4116. (c) Sakai, R.; Koike, T.; Sasaki,
M.; Shimamoto, K.; Oiwa, C.; Yano, A.; Suzuki, K.; Tachibana, K.; Kamiya,
H. Org. Lett. 2001, 3, 1479–1482.
metathesis partners are of type I8 and thus are highly reactive,
so significant amounts of the two self-metathesis products
were obtained. This was circumvented by using a 4:1 ratio
of the heptenitol to the allyl glycine, providing the decenoate
1 and a large amount of the easily separated heptenitol self-
metathesis product. While this strategy was tenable for the
readily available gluco-heptenitol 2, it was not feasible for
other heptenitols that may require greater synthetic effort.
To avoid this limitation, we present here a ring-closing
metathesis strategy that not only allows for a 1:1 stoichio-
metric ratio between the metathesis partners but also presents
the option of diverting the synthesis to yield stereospecif-
(8) Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J. Am.
Chem. Soc. 2003, 125, 11360–11370.
(9) Boschetti, A.; Nicotra, F.; Panza, L.; Russo, G. J. Org. Chem. 1988,
53, 4181–4185.
(10) David, S.; Hanessian, S. Tetrahedron 1985, 41, 643–663.
(11) Wang, H.; She, J.; Zhang, L.-H.; Ye, X. S. J. Org. Chem. 2004,
69, 5774–5777.
4912
Org. Lett., Vol. 10, No. 21, 2008